Report Detail
Global (United States, European Union and China) Non-prescription Drugs Market Research Report 2019-2025
- RnM3703709 |
- 28 August, 2019 |
- Global |
- 126 Pages |
- QYResearch |
- Pharma & Healthcare
A medication (also referred to as medicine, pharmaceutical drug, or simply drug) is a drug used to diagnose, cure, treat, or prevent disease. Drug therapy (pharmacotherapy) is an important part of the medical field and relies on the science of pharmacology for continual advancement and on pharmacy for appropriate management.
In 2019, the market size of Non-prescription Drugs is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Non-prescription Drugs.
This report studies the global market size of Non-prescription Drugs, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Non-prescription Drugs sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
Pfizer
Roche
Sanofi
Johnson & Johnson
Merck & Co. (MSD)
Novartis
AbbVie
Gilead Sciences
GlaxoSmithKline (GSK)
Amgen
AstraZeneca
Bristol-Myers Squibb
Eli Lilly
Teva
Bayer
Novo Nordisk
Allergan
Shire
Boehringer Ingelheim
Takeda
Market Segment by Product Type
Brand Drugs
Generic Drug
Market Segment by Application
Hospital
Clinic
Other
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the Non-prescription Drugs status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Non-prescription Drugs manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of Non-prescription Drugs are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
Table of Contents
1 Report Overview
- 1.1 Study Scope
- 1.2 Major Manufacturers Covered in This Report
- 1.3 Market Segment by Type
- 1.3.1 Global Non-prescription Drugs Market Size Growth Rate by Type (2019-2025)
- 1.3.2 Brand Drugs
- 1.3.3 Generic Drug
- 1.4 Market Segment by Application
- 1.4.1 Global Non-prescription Drugs Market Share by Application (2019-2025)
- 1.4.2 Hospital
- 1.4.3 Clinic
- 1.4.4 Other
- 1.5 Study Objectives
- 1.6 Years Considered
2 Global Growth Trends
- 2.1 Global Non-prescription Drugs Market Size
- 2.1.1 Global Non-prescription Drugs Revenue 2014-2025
- 2.1.2 Global Non-prescription Drugs Sales 2014-2025
- 2.2 Non-prescription Drugs Growth Rate by Regions
- 2.2.1 Global Non-prescription Drugs Sales by Regions 2014-2019
- 2.2.2 Global Non-prescription Drugs Revenue by Regions 2014-2019
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
3 Market Share by Manufacturers
- 3.1 Non-prescription Drugs Sales by Manufacturers
- 3.1.1 Non-prescription Drugs Sales by Manufacturers 2014-2019
- 3.1.2 Non-prescription Drugs Sales Market Share by Manufacturers 2014-2019
- 3.2 Revenue by Manufacturers
- 3.2.1 Non-prescription Drugs Revenue by Manufacturers (2014-2019)
- 3.2.2 Non-prescription Drugs Revenue Share by Manufacturers (2014-2019)
- 3.2.3 Global Non-prescription Drugs Market Concentration Ratio (CR5 and HHI)
- 3.3 Non-prescription Drugs Price by Manufacturers
- 3.4 Key Manufacturers Non-prescription Drugs Plants/Factories Distribution and Area Served
- 3.5 Date of Key Manufacturers Enter into Non-prescription Drugs Market
- 3.6 Key Manufacturers Non-prescription Drugs Product Offered
- 3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
- 4.1 Sales and Revenue for Each Type
- 4.1.1 Brand Drugs Sales and Revenue (2014-2019)
- 4.1.2 Generic Drug Sales and Revenue (2014-2019)
- 4.2 Global Non-prescription Drugs Sales Market Share by Type
- 4.3 Global Non-prescription Drugs Revenue Market Share by Type
- 4.4 Non-prescription Drugs Price by Type
5 Market Size by Application
- 5.1 Overview
- 5.2 Global Non-prescription Drugs Sales by Application
6 United States
- 6.1 United States Non-prescription Drugs Breakdown Data by Company
- 6.2 United States Non-prescription Drugs Breakdown Data by Type
- 6.3 United States Non-prescription Drugs Breakdown Data by Application
7 European Union
- 7.1 European Union Non-prescription Drugs Breakdown Data by Company
- 7.2 European Union Non-prescription Drugs Breakdown Data by Type
- 7.3 European Union Non-prescription Drugs Breakdown Data by Application
8 China
- 8.1 China Non-prescription Drugs Breakdown Data by Company
- 8.2 China Non-prescription Drugs Breakdown Data by Type
- 8.3 China Non-prescription Drugs Breakdown Data by Application
9 Rest of World
- 9.1 Rest of World Non-prescription Drugs Breakdown Data by Company
- 9.2 Rest of World Non-prescription Drugs Breakdown Data by Type
- 9.3 Rest of World Non-prescription Drugs Breakdown Data by Application
- 9.4 Rest of World Non-prescription Drugs Breakdown Data by Countries
- 9.4.1 Rest of World Non-prescription Drugs Sales by Countries
- 9.4.2 Rest of World Non-prescription Drugs Revenue by Countries
- 9.4.3 Japan
- 9.4.4 Korea
- 9.4.5 India
- 9.4.6 Southeast Asia
10 Company Profiles
- 10.1 Pfizer
- 10.1.1 Pfizer Company Details
- 10.1.2 Company Description and Business Overview
- 10.1.3 Sales, Revenue and Market Share of Non-prescription Drugs
- 10.1.4 Non-prescription Drugs Product Introduction
- 10.1.5 Pfizer Recent Development
- 10.2 Roche
- 10.2.1 Roche Company Details
- 10.2.2 Company Description and Business Overview
- 10.2.3 Sales, Revenue and Market Share of Non-prescription Drugs
- 10.2.4 Non-prescription Drugs Product Introduction
- 10.2.5 Roche Recent Development
- 10.3 Sanofi
- 10.3.1 Sanofi Company Details
- 10.3.2 Company Description and Business Overview
- 10.3.3 Sales, Revenue and Market Share of Non-prescription Drugs
- 10.3.4 Non-prescription Drugs Product Introduction
- 10.3.5 Sanofi Recent Development
- 10.4 Johnson & Johnson
- 10.4.1 Johnson & Johnson Company Details
- 10.4.2 Company Description and Business Overview
- 10.4.3 Sales, Revenue and Market Share of Non-prescription Drugs
- 10.4.4 Non-prescription Drugs Product Introduction
- 10.4.5 Johnson & Johnson Recent Development
- 10.5 Merck & Co. (MSD)
- 10.5.1 Merck & Co. (MSD) Company Details
- 10.5.2 Company Description and Business Overview
- 10.5.3 Sales, Revenue and Market Share of Non-prescription Drugs
- 10.5.4 Non-prescription Drugs Product Introduction
- 10.5.5 Merck & Co. (MSD) Recent Development
- 10.6 Novartis
- 10.6.1 Novartis Company Details
- 10.6.2 Company Description and Business Overview
- 10.6.3 Sales, Revenue and Market Share of Non-prescription Drugs
- 10.6.4 Non-prescription Drugs Product Introduction
- 10.6.5 Novartis Recent Development
- 10.7 AbbVie
- 10.7.1 AbbVie Company Details
- 10.7.2 Company Description and Business Overview
- 10.7.3 Sales, Revenue and Market Share of Non-prescription Drugs
- 10.7.4 Non-prescription Drugs Product Introduction
- 10.7.5 AbbVie Recent Development
- 10.8 Gilead Sciences
- 10.8.1 Gilead Sciences Company Details
- 10.8.2 Company Description and Business Overview
- 10.8.3 Sales, Revenue and Market Share of Non-prescription Drugs
- 10.8.4 Non-prescription Drugs Product Introduction
- 10.8.5 Gilead Sciences Recent Development
- 10.9 GlaxoSmithKline (GSK)
- 10.9.1 GlaxoSmithKline (GSK) Company Details
- 10.9.2 Company Description and Business Overview
- 10.9.3 Sales, Revenue and Market Share of Non-prescription Drugs
- 10.9.4 Non-prescription Drugs Product Introduction
- 10.9.5 GlaxoSmithKline (GSK) Recent Development
- 10.10 Amgen
- 10.10.1 Amgen Company Details
- 10.10.2 Company Description and Business Overview
- 10.10.3 Sales, Revenue and Market Share of Non-prescription Drugs
- 10.10.4 Non-prescription Drugs Product Introduction
- 10.10.5 Amgen Recent Development
- 10.11 AstraZeneca
- 10.12 Bristol-Myers Squibb
- 10.13 Eli Lilly
- 10.14 Teva
- 10.15 Bayer
- 10.16 Novo Nordisk
- 10.17 Allergan
- 10.18 Shire
- 10.19 Boehringer Ingelheim
- 10.20 Takeda
11 Value Chain and Sales Channels Analysis
- 11.1 Value Chain Analysis
- 11.2 Sales Channels Analysis
- 11.2.1 Non-prescription Drugs Sales Channels
- 11.2.2 Non-prescription Drugs Distributors
- 11.3 Non-prescription Drugs Customers
12 Market Forecast
- 12.1 Global Non-prescription Drugs Sales and Revenue Forecast 2019-2025
- 12.2 Global Non-prescription Drugs Sales Forecast by Type
- 12.3 Global Non-prescription Drugs Sales Forecast by Application
- 12.4 Non-prescription Drugs Forecast by Regions
- 12.4.1 Global Non-prescription Drugs Sales Forecast by Regions 2019-2025
- 12.4.2 Global Non-prescription Drugs Revenue Forecast by Regions 2019-2025
- 12.5 United States Market Forecast
- 12.6 European Union Market Forecast
- 12.7 China Market Forecast
- 12.8 Rest of World
- 12.8.1 Japan
- 12.8.2 Korea
- 12.8.3 India
13 Research Findings and Conclusion
14 Appendix
- 14.1 Research Methodology
- 14.1.1 Methodology/Research Approach
- 14.1.1.1 Research Programs/Design
- 14.1.1.2 Market Size Estimation
- 14.1.1.3 Market Breakdown and Data Triangulation
- 14.1.2 Data Source
- 14.1.2.1 Secondary Sources
- 14.1.2.2 Primary Sources
- 14.1.1 Methodology/Research Approach
- 14.2 Author Details
Summary:
Get latest Market Research Reports on Non-prescription Drugs. Industry analysis & Market Report on Non-prescription Drugs is a syndicated market report, published as Global (United States, European Union and China) Non-prescription Drugs Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of Non-prescription Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
